Optimizing antibiotics out of worm guts In vivo studies of the antibiotic darobactin D22 against high-priority gram-negative bacteria show promise for further drug development.

https://www.drugdiscoverynews.com/optimizing-antibiotics-out-of-worm-guts-16224